 | • レポートコード：GIR201111478 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、ゴナドトロピン放出ホルモン作動薬の世界市場を調査対象にし、ゴナドトロピン放出ホルモン作動薬の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（リュープロレリン、ゴセレリン、タルチレリン、ヒストレリン、その他）、用途別分析（病院、薬局、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：AbbVie、Sanofi、TerSera Therapeutics、AstraZeneca、Ipsen、Ferring、LIVZON、Takeda、Endo ・メーカー別販売量、売上、市場シェア ・ゴナドトロピン放出ホルモン作動薬の地域別市場分析 ・ゴナドトロピン放出ホルモン作動薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・ゴナドトロピン放出ホルモン作動薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・ゴナドトロピン放出ホルモン作動薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・ゴナドトロピン放出ホルモン作動薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・ゴナドトロピン放出ホルモン作動薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・ゴナドトロピン放出ホルモン作動薬の種類別市場規模2015-2020：リュープロレリン、ゴセレリン、タルチレリン、ヒストレリン、その他 ・ゴナドトロピン放出ホルモン作動薬の用途別市場規模2015-2020：病院、薬局、その他 ・ゴナドトロピン放出ホルモン作動薬の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Gonadotropin-releasing Hormone Agonist Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Gonadotropin-releasing Hormone Agonist Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Gonadotropin-releasing Hormone Agonist Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Gonadotropin-releasing Hormone Agonist Drugs market has been segmented into
Leuprorelin
Goserelin
Taltirelin
Histrelin
Other
By Application, Gonadotropin-releasing Hormone Agonist Drugs has been segmented into:
Hospital
Pharmacy
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Gonadotropin-releasing Hormone Agonist Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Gonadotropin-releasing Hormone Agonist Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Gonadotropin-releasing Hormone Agonist Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Gonadotropin-releasing Hormone Agonist Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Gonadotropin-releasing Hormone Agonist Drugs Market Share Analysis
Gonadotropin-releasing Hormone Agonist Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Gonadotropin-releasing Hormone Agonist Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Gonadotropin-releasing Hormone Agonist Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Gonadotropin-releasing Hormone Agonist Drugs are:
AbbVie
Sanofi
TerSera Therapeutics
AstraZeneca
Ipsen
Ferring
LIVZON
Takeda
Endo
Among other players domestic and global, Gonadotropin-releasing Hormone Agonist Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gonadotropin-releasing Hormone Agonist Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gonadotropin-releasing Hormone Agonist Drugs, with price, sales, revenue and global market share of Gonadotropin-releasing Hormone Agonist Drugs in 2018 and 2019.
Chapter 3, the Gonadotropin-releasing Hormone Agonist Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gonadotropin-releasing Hormone Agonist Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Gonadotropin-releasing Hormone Agonist Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Gonadotropin-releasing Hormone Agonist Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Gonadotropin-releasing Hormone Agonist Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Leuprorelin
1.2.3 Goserelin
1.2.4 Taltirelin
1.2.5 Histrelin
1.2.6 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Overview of Global Gonadotropin-releasing Hormone Agonist Drugs Market
1.4.1 Global Gonadotropin-releasing Hormone Agonist Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AbbVie SWOT Analysis
2.1.4 AbbVie Product and Services
2.1.5 AbbVie Gonadotropin-releasing Hormone Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sanofi SWOT Analysis
2.2.4 Sanofi Product and Services
2.2.5 Sanofi Gonadotropin-releasing Hormone Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 TerSera Therapeutics
2.3.1 TerSera Therapeutics Details
2.3.2 TerSera Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 TerSera Therapeutics SWOT Analysis
2.3.4 TerSera Therapeutics Product and Services
2.3.5 TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 AstraZeneca
2.4.1 AstraZeneca Details
2.4.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 AstraZeneca SWOT Analysis
2.4.4 AstraZeneca Product and Services
2.4.5 AstraZeneca Gonadotropin-releasing Hormone Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Ipsen
2.5.1 Ipsen Details
2.5.2 Ipsen Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Ipsen SWOT Analysis
2.5.4 Ipsen Product and Services
2.5.5 Ipsen Gonadotropin-releasing Hormone Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Ferring
2.6.1 Ferring Details
2.6.2 Ferring Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Ferring SWOT Analysis
2.6.4 Ferring Product and Services
2.6.5 Ferring Gonadotropin-releasing Hormone Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 LIVZON
2.7.1 LIVZON Details
2.7.2 LIVZON Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 LIVZON SWOT Analysis
2.7.4 LIVZON Product and Services
2.7.5 LIVZON Gonadotropin-releasing Hormone Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Takeda
2.8.1 Takeda Details
2.8.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Takeda SWOT Analysis
2.8.4 Takeda Product and Services
2.8.5 Takeda Gonadotropin-releasing Hormone Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Endo
2.9.1 Endo Details
2.9.2 Endo Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Endo SWOT Analysis
2.9.4 Endo Product and Services
2.9.5 Endo Gonadotropin-releasing Hormone Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Gonadotropin-releasing Hormone Agonist Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Gonadotropin-releasing Hormone Agonist Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020)
4.5 South America Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Gonadotropin-releasing Hormone Agonist Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Gonadotropin-releasing Hormone Agonist Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Gonadotropin-releasing Hormone Agonist Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020)
6.3 UK Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020)
6.4 France Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Gonadotropin-releasing Hormone Agonist Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Gonadotropin-releasing Hormone Agonist Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020)
7.5 India Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Gonadotropin-releasing Hormone Agonist Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Gonadotropin-releasing Hormone Agonist Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Gonadotropin-releasing Hormone Agonist Drugs Price by Type (2015-2020)
11 Global Gonadotropin-releasing Hormone Agonist Drugs Market Segment by Application
11.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2015-2020)
11.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Gonadotropin-releasing Hormone Agonist Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Gonadotropin-releasing Hormone Agonist Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Gonadotropin-releasing Hormone Agonist Drugs Market Forecast (2021-2025)
12.2.2 Europe Gonadotropin-releasing Hormone Agonist Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Gonadotropin-releasing Hormone Agonist Drugs Market Forecast (2021-2025)
12.2.4 South America Gonadotropin-releasing Hormone Agonist Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Market Forecast (2021-2025)
12.3 Gonadotropin-releasing Hormone Agonist Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Gonadotropin-releasing Hormone Agonist Drugs Market Share Forecast by Type (2021-2025)
12.4 Gonadotropin-releasing Hormone Agonist Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Gonadotropin-releasing Hormone Agonist Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Gonadotropin-releasing Hormone Agonist Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. AbbVie Basic Information, Manufacturing Base and Competitors
Table 8. AbbVie Gonadotropin-releasing Hormone Agonist Drugs Major Business
Table 9. AbbVie Gonadotropin-releasing Hormone Agonist Drugs Total Revenue (USD Million) (2017-2018)
Table 10. AbbVie SWOT Analysis
Table 11. AbbVie Gonadotropin-releasing Hormone Agonist Drugs Product and Services
Table 12. AbbVie Gonadotropin-releasing Hormone Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Sanofi Basic Information, Manufacturing Base and Competitors
Table 14. Sanofi Gonadotropin-releasing Hormone Agonist Drugs Major Business
Table 15. Sanofi Gonadotropin-releasing Hormone Agonist Drugs Total Revenue (USD Million) (2017-2018)
Table 16. Sanofi SWOT Analysis
Table 17. Sanofi Gonadotropin-releasing Hormone Agonist Drugs Product and Services
Table 18. Sanofi Gonadotropin-releasing Hormone Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. TerSera Therapeutics Basic Information, Manufacturing Base and Competitors
Table 20. TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Drugs Major Business
Table 21. TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Drugs Total Revenue (USD Million) (2017-2018)
Table 22. TerSera Therapeutics SWOT Analysis
Table 23. TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Drugs Product and Services
Table 24. TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 26. AstraZeneca Gonadotropin-releasing Hormone Agonist Drugs Major Business
Table 27. AstraZeneca Gonadotropin-releasing Hormone Agonist Drugs Total Revenue (USD Million) (2017-2018)
Table 28. AstraZeneca SWOT Analysis
Table 29. AstraZeneca Gonadotropin-releasing Hormone Agonist Drugs Product and Services
Table 30. AstraZeneca Gonadotropin-releasing Hormone Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Ipsen Basic Information, Manufacturing Base and Competitors
Table 32. Ipsen Gonadotropin-releasing Hormone Agonist Drugs Major Business
Table 33. Ipsen Gonadotropin-releasing Hormone Agonist Drugs Total Revenue (USD Million) (2017-2018)
Table 34. Ipsen SWOT Analysis
Table 35. Ipsen Gonadotropin-releasing Hormone Agonist Drugs Product and Services
Table 36. Ipsen Gonadotropin-releasing Hormone Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Ferring Basic Information, Manufacturing Base and Competitors
Table 38. Ferring Gonadotropin-releasing Hormone Agonist Drugs Major Business
Table 39. Ferring Gonadotropin-releasing Hormone Agonist Drugs Total Revenue (USD Million) (2017-2018)
Table 40. Ferring SWOT Analysis
Table 41. Ferring Gonadotropin-releasing Hormone Agonist Drugs Product and Services
Table 42. Ferring Gonadotropin-releasing Hormone Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. LIVZON Basic Information, Manufacturing Base and Competitors
Table 44. LIVZON Gonadotropin-releasing Hormone Agonist Drugs Major Business
Table 45. LIVZON Gonadotropin-releasing Hormone Agonist Drugs Total Revenue (USD Million) (2017-2018)
Table 46. LIVZON SWOT Analysis
Table 47. LIVZON Gonadotropin-releasing Hormone Agonist Drugs Product and Services
Table 48. LIVZON Gonadotropin-releasing Hormone Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Takeda Basic Information, Manufacturing Base and Competitors
Table 50. Takeda Gonadotropin-releasing Hormone Agonist Drugs Major Business
Table 51. Takeda Gonadotropin-releasing Hormone Agonist Drugs Total Revenue (USD Million) (2017-2018)
Table 52. Takeda SWOT Analysis
Table 53. Takeda Gonadotropin-releasing Hormone Agonist Drugs Product and Services
Table 54. Takeda Gonadotropin-releasing Hormone Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Endo Basic Information, Manufacturing Base and Competitors
Table 56. Endo Gonadotropin-releasing Hormone Agonist Drugs Major Business
Table 57. Endo Gonadotropin-releasing Hormone Agonist Drugs Total Revenue (USD Million) (2017-2018)
Table 58. Endo SWOT Analysis
Table 59. Endo Gonadotropin-releasing Hormone Agonist Drugs Product and Services
Table 60. Endo Gonadotropin-releasing Hormone Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 62. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 63. Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Regions (2015-2020) (K Units)
Table 64. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Regions (2015-2020)
Table 65. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Regions (2015-2020) (USD Million)
Table 66. North America Gonadotropin-releasing Hormone Agonist Drugs Sales by Countries (2015-2020) (K Units)
Table 67. North America Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Countries (2015-2020)
Table 68. North America Gonadotropin-releasing Hormone Agonist Drugs Revenue by Countries (2015-2020) (USD Million)
Table 69. North America Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Countries (2015-2020)
Table 70. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales by Countries (2015-2020) (K Units)
Table 71. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Countries (2015-2020)
Table 72. Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue by Countries (2015-2020) (USD Million)
Table 73. Asia-Pacific Gonadotropin-releasing Hormone Agonist Drugs Sales by Regions (2015-2020) (K Units)
Table 74. Asia-Pacific Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Regions (2015-2020)
Table 75. Asia-Pacific Gonadotropin-releasing Hormone Agonist Drugs Revenue by Regions (2015-2020) (USD Million)
Table 76. South America Gonadotropin-releasing Hormone Agonist Drugs Sales by Countries (2015-2020) (K Units)
Table 77. South America Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Countries (2015-2020)
Table 78. South America Gonadotropin-releasing Hormone Agonist Drugs Revenue by Countries (2015-2020) (USD Million)
Table 79. South America Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Countries (2015-2020)
Table 80. Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Sales by Countries (2015-2020) (K Units)
Table 81. Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Countries (2015-2020)
Table 82. Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue by Countries (2015-2020) (USD Million)
Table 83. Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Countries (2015-2020)
Table 84. Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Type (2015-2020) (K Units)
Table 85. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Share by Type (2015-2020)
Table 86. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Type (2015-2020) (USD Million)
Table 87. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Share by Type (2015-2020)
Table 88. Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Application (2015-2020) (K Units)
Table 89. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Share by Application (2015-2020)
Table 90. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Forecast by Regions (2021-2025) (K Units)
Table 91. Global Gonadotropin-releasing Hormone Agonist Drugs Market Share Forecast by Regions (2021-2025)
Table 92. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Forecast by Type (2021-2025) (K Units)
Table 93. Global Gonadotropin-releasing Hormone Agonist Drugs Market Share Forecast by Type (2021-2025)
Table 94. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Forecast by Application (2021-2025)
Table 95. Global Gonadotropin-releasing Hormone Agonist Drugs Market Share Forecast by Application (2021-2025)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Gonadotropin-releasing Hormone Agonist Drugs Picture
Figure 2. Global Sales Market Share of Gonadotropin-releasing Hormone Agonist Drugs by Type in 2019
Figure 3. Leuprorelin Picture
Figure 4. Goserelin Picture
Figure 5. Taltirelin Picture
Figure 6. Histrelin Picture
Figure 7. Other Picture
Figure 8. Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application in 2018
Figure 9. Hospital Picture
Figure 10. Pharmacy Picture
Figure 11. Other Picture
Figure 12. Global Gonadotropin-releasing Hormone Agonist Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Gonadotropin-releasing Hormone Agonist Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Gonadotropin-releasing Hormone Agonist Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Gonadotropin-releasing Hormone Agonist Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Gonadotropin-releasing Hormone Agonist Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Gonadotropin-releasing Hormone Agonist Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Gonadotropin-releasing Hormone Agonist Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Gonadotropin-releasing Hormone Agonist Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Gonadotropin-releasing Hormone Agonist Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Gonadotropin-releasing Hormone Agonist Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Gonadotropin-releasing Hormone Agonist Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Gonadotropin-releasing Hormone Agonist Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Gonadotropin-releasing Hormone Agonist Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Gonadotropin-releasing Hormone Agonist Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Gonadotropin-releasing Hormone Agonist Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Gonadotropin-releasing Hormone Agonist Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Gonadotropin-releasing Hormone Agonist Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Gonadotropin-releasing Hormone Agonist Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Gonadotropin-releasing Hormone Agonist Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Manufacturer in 2019
Figure 33. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Gonadotropin-releasing Hormone Agonist Drugs Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Gonadotropin-releasing Hormone Agonist Drugs Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 38. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Regions (2015-2020)
Figure 40. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Regions in 2018
Figure 41. North America Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020)
Figure 42. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020)
Figure 44. South America Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020)
Figure 46. North America Gonadotropin-releasing Hormone Agonist Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Countries (2015-2020)
Figure 48. North America Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Countries in 2018
Figure 49. North America Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Countries in 2018
Figure 51. United States Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Canada Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Mexico Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Countries in 2019
Figure 57. Germany Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 58. UK Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 59. France Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Russia Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Italy Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Asia-Pacific Gonadotropin-releasing Hormone Agonist Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Regions 2019
Figure 65. China Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Japan Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Korea Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 68. India Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Southeast Asia Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 70. South America Gonadotropin-releasing Hormone Agonist Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Countries in 2019
Figure 72. South America Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Countries in 2019
Figure 73. Brazil Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Argentina Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Egypt Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Turkey Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 82. South Africa Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Global Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2021-2025) (K Units)
Figure 84. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Gonadotropin-releasing Hormone Agonist Drugs Market Forecast (2021-2025) (K Units)
Figure 86. Europe Sales Gonadotropin-releasing Hormone Agonist Drugs Market Forecast (2021-2025) (K Units)
Figure 87. Asia-Pacific Sales Gonadotropin-releasing Hormone Agonist Drugs Market Forecast (2021-2025) (K Units)
Figure 88. South America Sales Gonadotropin-releasing Hormone Agonist Drugs Market Forecast (2021-2025) (K Units)
Figure 89. Middle East & Africa Sales Gonadotropin-releasing Hormone Agonist Drugs Market Forecast (2021-2025) (K Units)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
ゴナドトロピン放出ホルモンアゴニストの世界市場 2020年 Market Overview The global Gonadotropin-releasing Hormone Agonist market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Gonado…- 黄体形成ホルモン放出ホルモン類似体薬の世界市場 2020年 Market Overview The global Luteinizing Hormone-releasing Hormone Analogs Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 201…
- 黄体形成ホルモン放出ホルモン類似体の世界市場 2020年 Market Overview The global Luteinizing Hormone-releasing Hormone Analogs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The…
- グルカゴン様ペプチド-2（GLP-2）アゴニストの世界市場 2020年 Market Overview The global Glucagon-like Peptide-2 (GLP-2) Agonist market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Gluca…
- 成長ホルモン抑制ホルモンの世界市場 2020年 Market Overview The global Growth Hormone-inhibiting Hormone market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Growth Horm…